The researchers have claimed that the COVID vaccine invented by the UK’s University of Oxford and the pharmaceutical company AstraZeneca is very safe and effective.
Medical journal The Lancet also confirmed that the vaccine helps reduce the death rate by Covid-19, according to a report of BBC published on Tuesday.
This is the first peer-reviewed analysis of the final phase of the Oxford vaccine clinical trial. Scientists are exchanging information among themselves to ensure transparency about the vaccine. They hope the vaccine will be approved in several countries, including the United Kingdom and India, in the next few weeks.
According to the study, 11,337 volunteers in the United Kingdom and Brazil are taking part in clinical trials of the vaccine. Interim results of the vaccine show that it is 70 percent effective overall.
Vaccine tests have shown that when applied in full two doses, the efficacy is at least 62 percent. However, up to 90 percent of the vaccine is effective if the first dose is given in half dose and the second dose in full dose.
Researchers say that almost everyone who took part in the trial has recovered or is recovering.
Citing research, Business Insider reports that the vaccine was administered to a total of 23,745 volunteers. It has been found to have side effects on the bodies of three after vaccination.It is to be noted that the test results have been sent to drug regulators around the world for approval. The Oxford vaccine has been applied for urgent use in several countries, including the United Kingdom and India. However, there are still some questions about the vaccine and that is the amount of dose. Source: https://www.daily-bangladesh.com
